These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30072890)

  • 1. Dissociation of Tau Deposits and Brain Atrophy in Early Alzheimer's Disease: A Combined Positron Emission Tomography/Magnetic Resonance Imaging Study.
    Shigemoto Y; Sone D; Imabayashi E; Maikusa N; Okamura N; Furumoto S; Kudo Y; Ogawa M; Takano H; Yokoi Y; Sakata M; Tsukamoto T; Kato K; Sato N; Matsuda H
    Front Aging Neurosci; 2018; 10():223. PubMed ID: 30072890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between quantitative [
    Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
    Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative
    Zhao Q; Liu M; Ha L; Zhou Y;
    Front Neurol; 2019; 10():486. PubMed ID: 31156534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of appropriate partial volume correction for PET quantification in Alzheimer's disease.
    Thomas BA; Erlandsson K; Modat M; Thurfjell L; Vandenberghe R; Ourselin S; Hutton BF
    Eur J Nucl Med Mol Imaging; 2011 Jun; 38(6):1104-19. PubMed ID: 21336694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional tau deposition and subregion atrophy of medial temporal structures in early Alzheimer's disease: A combined positron emission tomography/magnetic resonance imaging study.
    Sone D; Imabayashi E; Maikusa N; Okamura N; Furumoto S; Kudo Y; Ogawa M; Takano H; Yokoi Y; Sakata M; Tsukamoto T; Kato K; Matsuda H
    Alzheimers Dement (Amst); 2017; 9():35-40. PubMed ID: 28856235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual tracer tau PET imaging reveals different molecular targets for
    Chiotis K; Stenkrona P; Almkvist O; Stepanov V; Ferreira D; Arakawa R; Takano A; Westman E; Varrone A; Okamura N; Shimada H; Higuchi M; Halldin C; Nordberg A
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1605-1617. PubMed ID: 29752516
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Xu X; Ruan W; Liu F; Gai Y; Liu Q; Su Y; Liang Z; Sun X; Lan X
    Front Aging Neurosci; 2021; 13():789054. PubMed ID: 35221982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of five partial volume correction methods for Tau and Amyloid PET imaging with [
    Shidahara M; Thomas BA; Okamura N; Ibaraki M; Matsubara K; Oyama S; Ishikawa Y; Watanuki S; Iwata R; Furumoto S; Tashiro M; Yanai K; Gonda K; Watabe H
    Ann Nucl Med; 2017 Aug; 31(7):563-569. PubMed ID: 28639126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual cognition in non-amnestic Alzheimer's disease: Relations to tau, amyloid, and cortical atrophy.
    Putcha D; Brickhouse M; Touroutoglou A; Collins JA; Quimby M; Wong B; Eldaief M; Schultz A; El Fakhri G; Johnson K; Dickerson BC; McGinnis SM
    Neuroimage Clin; 2019; 23():101889. PubMed ID: 31200149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau Pathology Distribution in Alzheimer's disease Corresponds Differentially to Cognition-Relevant Functional Brain Networks.
    Hansson O; Grothe MJ; Strandberg TO; Ohlsson T; Hägerström D; Jögi J; Smith R; Schöll M
    Front Neurosci; 2017; 11():167. PubMed ID: 28408865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the Precuneus/Posterior Cingulate Cortex Is Significant for the Development of Alzheimer's Disease: A PET (THK5351, PiB) and Resting fMRI Study.
    Yokoi T; Watanabe H; Yamaguchi H; Bagarinao E; Masuda M; Imai K; Ogura A; Ohdake R; Kawabata K; Hara K; Riku Y; Ishigaki S; Katsuno M; Miyao S; Kato K; Naganawa S; Harada R; Okamura N; Yanai K; Yoshida M; Sobue G
    Front Aging Neurosci; 2018; 10():304. PubMed ID: 30344488
    [No Abstract]   [Full Text] [Related]  

  • 12. Positron emission tomography metabolic data corrected for cortical atrophy using magnetic resonance imaging.
    Labbé C; Froment JC; Kennedy A; Ashburner J; Cinotti L
    Alzheimer Dis Assoc Disord; 1996; 10(3):141-70. PubMed ID: 8876777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau positron emission tomography using [
    Kang JM; Lee SY; Seo S; Jeong HJ; Woo SH; Lee H; Lee YB; Yeon BK; Shin DH; Park KH; Kang H; Okamura N; Furumoto S; Yanai K; Villemagne VL; Seong JK; Na DL; Ido T; Cho J; Lee KM; Noh Y
    Neurobiol Aging; 2017 Nov; 59():210-219. PubMed ID: 28890300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial-Volume Effect Correction Improves Quantitative Analysis of 18F-Florbetaben β-Amyloid PET Scans.
    Rullmann M; Dukart J; Hoffmann KT; Luthardt J; Tiepolt S; Patt M; Gertz HJ; Schroeter ML; Seibyl J; Schulz-Schaeffer WJ; Sabri O; Barthel H
    J Nucl Med; 2016 Feb; 57(2):198-203. PubMed ID: 26541776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer's Disease Patients Measured Using [18F] THK-5351.
    Lockhart SN; Baker SL; Okamura N; Furukawa K; Ishiki A; Furumoto S; Tashiro M; Yanai K; Arai H; Kudo Y; Harada R; Tomita N; Hiraoka K; Watanuki S; Jagust WJ
    PLoS One; 2016; 11(6):e0158460. PubMed ID: 27355840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topographical Heterogeneity of Alzheimer's Disease Based on MR Imaging, Tau PET, and Amyloid PET.
    Jeon S; Kang JM; Seo S; Jeong HJ; Funck T; Lee SY; Park KH; Lee YB; Yeon BK; Ido T; Okamura N; Evans AC; Na DL; Noh Y
    Front Aging Neurosci; 2019; 11():211. PubMed ID: 31481888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Centiloid scale analysis for
    Yamao T; Miwa K; Wagatsuma K; Shigemoto Y; Sato N; Akamatsu G; Ito H; Matsuda H
    Phys Med; 2021 Feb; 82():249-254. PubMed ID: 33677386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodistribution and Dosimetry Evaluation for a Novel Tau Tracer [
    Wang Y; Cai L; Zhou K; Cui M; Yao S
    Front Bioeng Biotechnol; 2021; 9():812818. PubMed ID: 35223820
    [No Abstract]   [Full Text] [Related]  

  • 20. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
    Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
    Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.